CTXR NASDAQ · Healthcare · FY 2025-09-30
Citius Pharmaceuticals, Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Unknown
Buy zone
Unknown
Archetype
Distressed/Deficit
Confidence
○○○
Insufficient · 0/4
Price
0.570 USD
Market cap
10.3M USD
P / B
0.15
P / E
—
EPS
-3.380
DPS / yield
— (0.0%)
NAV / share
-1.363
Graham number
—
Z'' score
-7.44
Piotroski F
3 / 9
Beneish M
—
ROIC vs WACC
-53.7%
vs 11.3%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.